Liability Claims In Pa. Prevacid Suit Pared, Punitives Allowed

Law360, Philadelphia (October 22, 2012, 3:24 PM EDT) -- A Pennsylvania federal judge Thursday narrowed product liability claims against Takeda Pharmaceuticals North America Inc. over the company’s acid reflux medication Prevacid but determined that the plaintiff could seek punitive damages.

U.S. District Judge Jane DuBois determined that David Tatum’s allegations that the drug weakened his bones, causing him to require a hip replacement, did not merit claims for strict liability based on design defect or failure to warn under Pennsylvania law, but she let a range of other claims move forward and rejected Takeda’s efforts...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

TATUM v. TAKEDA PHARMACEUTICALS NORTH AMERICA, INC. et al


Case Number

2:12-cv-01114

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Judge

JAN E. DUBOIS

Date Filed

March 1, 2012

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.